المؤلفون: Castillo-Ribelles L; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain., Arranz-Amo JA; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Hernández-Vara J; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Samaniego-Toro D; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Enriquez-Calzada S; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Pozo SL; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Neurology Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Department of Clinical and Movement Neurosciences, University College London Queen Square Institute of Neurology, London WC1N 3BG, U.K., Camprodon-Gomez M; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Unit of Hereditary Metabolic Disorders, Internal Medicine Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain., Laguna A; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Gonzalo MA; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Ferrer R; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain., Martinez-Vicente M; Departament de Bioquímica i Biologia Molecular, Universitat Autònoma de Barcelona, Bellaterra, Barcelona 08193, Spain.; Neurodegenerative Diseases Research Group- Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain., Carnicer-Caceres C; Clinical Biochemistry Department, Vall d'Hebron University Hospital, Barcelona 08035, Spain.; Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Research Group, Vall d'Hebron Research Institute (VHIR), Vall d'Hebron Barcelona Hospital Campus, Barcelona 08035, Spain.

المصدر: Analytical chemistry [Anal Chem] 2024 Aug 06; Vol. 96 (31), pp. 12875-12882. Date of Electronic Publication: 2024 Jul 24.

نوع المنشور: Journal Article; Evaluation Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0370536 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6882 (Electronic) Linking ISSN: 00032700 NLM ISO Abbreviation: Anal Chem Subsets: MEDLINE

مواضيع طبية MeSH: Parkinson Disease*/cerebrospinal fluid , Tandem Mass Spectrometry* , Glucosylceramides*/cerebrospinal fluid , Galactosylceramides*/cerebrospinal fluid, Humans ; Chromatography, High Pressure Liquid ; Biomarkers/cerebrospinal fluid ; Glucosylceramidase/cerebrospinal fluid ; Glucosylceramidase/genetics